For the year ending 2025-12-31, AIP had $20,178K increase in cash & cash equivalents over the period. $5,345K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -34,746 |
| Depreciation and amortization | 3,376 |
| Stock-based compensation | 18,376 |
| Pension plan expenses | 201 |
| Amortization of deferred income | 1,179 |
| Loss from equity method investment | -2,813 |
| Net accretion of discounts on available-for-sale securities | 368 |
| Other, net | -401 |
| Accounts receivable, net | -1,425 |
| Prepaid expenses and other assets | 6,347 |
| Accounts payable | -191 |
| Accrued expenses and other liabilities | 3,253 |
| Deferred revenue | 19,719 |
| Net cash provided by (used in) operating activities | 6,733 |
| Purchases of property and equipment | 1,388 |
| Purchases of available-for-sale securities and other | 29,528 |
| Proceeds from maturities and sales of available-for-sale securities and other | 42,944 |
| Net cash provided by investing activities | 12,028 |
| Principal payments under vendor financing arrangements | 1,503 |
| Proceeds from exercise of stock options | 1,866 |
| Proceeds from employee stock purchase plan | 982 |
| Other financing activities | 72 |
| Net cash provided by (used in) financing activities | 1,417 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 20,178 |
| Cash and cash equivalents at beginning of period | 14,072 |
| Cash and cash equivalents at end of period | 34,250 |
Arteris, Inc. (AIP)
Arteris, Inc. (AIP)